Hemophilia Market is projected to surge ahead at a CAGR of 7.60% from 2024 to 2032
Hemophilia Market Size Was Valued at USD 14.05 Billion in 2023 and is Projected to Reach USD 27.17 Billion by 2032, Growing at a CAGR of 7.60% From 2024-2032.
Hemophilia patients can manage their condition more effectively with treatments like emicizumab and other single-injection therapies, which reduce the frequency and complexity of care. Additionally, physical...